Project
multicenter, double-blind, placebo-controlled, parallel-group, phase IV study to assess the effect of Rotigotine on non-motor symptoms in patients with idiopathic parkinson's disease
Automatically Closed · 2011 until 2012
Tettenborn Barbara, Kägi Georg, Brugger Florian, Hägele-Link Stefan
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2011
End Date
2012
Financing
Industry
Brief description/objective
Multizentrische, doppelblinde, placebokontrollierte Parallelgruppenstudie der Phase IV zur Bestimmung der Wirkung von Rotigotin auf die nichtmotorischen Symptome bei Patienten mit idiopathischem Parkinson-Syndrom
Studie SP0976